SHISX holdings — BlackRock Health Sciences Opportunities Portfolio
BlackRock Health Sciences Opportunities Portfolio (SHISX) held 155 positions with net assets of $5.91B as of May 29, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 52.0% of the fund, led by LLY, JNJ, UNH.
SHISX top holdings
- LLY ELI LILLY & COMPANY — 12.29% ($726M)
- JNJ JOHNSON & JOHNSON — 8.77% ($518M)
- UNH UNITEDHEALTH GROUP INC — 6.10% ($360M)
- MRK MERCK & COMPANY INC — 4.94% ($292M)
- GILD GILEAD SCIENCES INC — 4.19% ($248M)
- ABBV ABBVIE INC — 3.94% ($233M)
- AMGN AMGEN INC — 3.37% ($199M)
- TMO THERMO FISHER SCIENTIFIC INC — 3.02% ($178M)
- VRTX VERTEX PHARMACEUTICALS INC — 2.74% ($162M)
- PFE PFIZER INC — 2.61% ($154M)
- EW EDWARDS LIFESCIENCES CORP — 2.51% ($148M)
- DHR DANAHER CORP — 2.00% ($118M)
- ABT ABBOTT LABORATORIES — 1.97% ($117M)
- ISRG INTUITIVE SURGICAL INC — 1.95% ($115M)
- TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD — 1.87% ($110M)
- BSX BOSTON SCIENTIFIC CORP — 1.59% ($94.0M)
- ELV ELEVANCE HEALTH INC — 1.56% ($92.4M)
- ARGX ARGENX SE — 1.26% ($74.4M)
- BIIB BIOGEN INC — 1.21% ($71.4M)
- AZN ASTRAZENECA PLC — 1.21% ($71.4M)
- SYK STRYKER CORP — 1.15% ($67.7M)
- BISXX BLACKROCK FUNDS III — 1.01% ($59.5M)
- RVMD REVOLUTION MEDICINES INC — 0.96% ($56.9M)
- HUM HUMANA INC — 0.92% ($54.4M)
- REGN REGENERON PHARMACEUTICALS INC — 0.91% ($53.9M)
What are SHISX's top 10 holdings?
LLY (12.3%), JNJ (8.8%), UNH (6.1%), MRK (4.9%), GILD (4.2%), ABBV (3.9%), AMGN (3.4%), TMO (3.0%), VRTX (2.7%), PFE (2.6%).
How many stocks are in SHISX?
BlackRock Health Sciences Opportunities Portfolio reported 155 holdings as of May 29, 2026.
Share classes: SHISX, SHSAX, SHSCX, SHSSX